CALIFORNIA LIFE SCIENCES ANNOUNCES 2021 PANTHEON AWARD WINNERS

Back

SOUTH SAN FRANCISCO, Calif. – Today, California Life Sciences (CLS) announced its 2021 Pantheon award winners–an annual celebration of those companies and individuals making significant scientific, business, and community contributions across California.

Due to safety considerations related to COVID, in lieu of an in-person event, Pantheon winners were announced via a video on the California Life Sciences website.

For the first time in 18 years, award winners were chosen by a public voting campaign that garnered more than 3,000 unique voters and represented categories in leadership, education, partnership, product innovation, and other achievements.

This year’s slate of finalists was selected by the Pantheon advisory committee, who collaboratively reviewed the record breaking nominations, and were instrumental in helping CLS champion the transformative work these individuals and organizations are doing, despite a difficult year.

Please join us in congratulating the 2021 Pantheon Award winners:

Life Science Leadership:

  • Frances H. Arnold, Ph.D.
  • Emil D. Kakkis, M.D., Ph.D.

Company of the Year:

  • Gilead Sciences
  • Product of the Year (Therapeutic):
  • LUMAKRAS™ (sotorasib) 120 mg tablets by Amgen

Product of the Year (Medical Device or Diagnostic):

  • IpsiHand, Neurolutions

Strategic Partnership of the Year

  • Kite, a Gilead Company, and Shoreline Biosciences, Inc.

Elizabeth Schar Inspiring Future Leaders:

  • Berkeley Engineering’s Bay Area Teen Science (B.A.T.S.)

Rising Star:

  • Scribe Therapeutics

Scientific Advancement:

  • Sonja Schrepfer, M.D., Ph.D.

Sponsors who generously supported the 2021 Pantheon Awards include AbbVie, Avantor, Amgen, Alexandria Real Estate Equities, Boehringer Ingelheim, CLS FAST, Latham & Watkins, Johnson & Johnson Innovation, Cooley, CytomX Therapeutics, Dendreon, Google Cloud, and Merck.

We look forward to welcoming our members and industry partners to next year’s Pantheon celebration scheduled for November 3, 2022 at Westin St Francis, San Francisco.

About California Life Sciences (CLS)

California Life Sciences (CLS) is the state’s most influential and impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. As integral components of a healthy and collaborative ecosystem, CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. With offices in South San Francisco, San Diego, Sacramento, Los Angeles, and Washington DC, CLS works to shape public policy, improve access to breakthrough technologies, educate lawmakers, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. In doing so, CLS fulfills its mission to protect and nurture California’s life sciences industry, empowering discoveries that lead to healthier lives around the world. #WeAreCaliforniaLifeSciences

Visit CLS at www.califesciences.org, and follow us on Twitter @CALifeSciencesFacebookLinkedIn and YouTube.

 

MEDIA CONTACT:

Alex Burch

California Life Sciences

(320) 237-7034

[email protected]